Learn More
Human ErbB2/Her2 (Research Grade Trastuzumab Biosimilar) Antibody, R&D Systems™

Description
Specifications
Specifications
| Antigen | ErbB2/Her2 |
| Applications | Flow Cytometry, Inhibition Assays, CyTOF |
| Classification | Monoclonal |
| Clone | Hu5 |
| Conjugate | Unconjugated |
| Dilution | Flow Cytometry 0.25 ug/10^6 cells, Inhibition of Cell Growth 15-75 ng/mL, CyTOF-ready |
| Formulation | Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. |
| Gene Alias | CD340, CD340 antigen, c-erb B2/neu protein, EC 2.7.10, EGFR2, HER2, HER-2, HER2EC 2.7.10.1, herstatin, Metastatic lymph node gene 19 protein, MLN 19, MLN19, Neu Oncogene, NEUHER-2/neu, neuroblastoma/glioblastoma derived oncogene homolog, NGL, NGLTKR1, p185erbB2, Proto-oncogene c-ErbB-2, Proto-oncogene Neu, receptor tyrosine-protein kinase erbB-2, TKR1, Tyrosine kinase-type cell surface receptor HER2, v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2(neuro/glioblastoma derived oncogene homolog), v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastomaderived oncogene homolog (avian) |
| Host Species | Human |
| Immunogen | Human ErbB2/Her2 |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.